Opportunity Information: Apply for RFA AG 20 021
The Nathan Shock Centers Coordinating Center (NSC3) funding opportunity (RFA-AG-20-021) is a National Institutes of Health (NIH) initiative, led through the National Institute on Aging (NIA), to create and run a central coordinating hub for the network of Nathan Shock Centers (NSCs). It uses a U24 cooperative agreement mechanism, which generally means the awardee is expected to work closely with NIH program staff and the NSC network in an ongoing, collaborative way rather than operating entirely independently. The FOA is focused on research infrastructure and coordination in the aging field, and it is explicitly labeled "Clinical Trial Not Allowed," so proposals must avoid proposing or embedding clinical trials as part of the supported activities.
The core purpose of the NSC3 is to strengthen the overall impact and cohesion of the Nathan Shock Centers as a national resource for aging research. The coordinating center is expected to raise the visibility of the NSCs both nationally and internationally, meaning it should actively promote what the centers offer, highlight scientific and technical capabilities, and help outside researchers understand how to access NSC resources. A major emphasis is improving collaboration and coordination across the separate NSCs so the network functions more like an integrated system rather than a set of standalone centers. This includes helping centers share best practices, align approaches where it makes sense, and reduce duplication so resources and expertise can be leveraged across the network.
Training is another central component. The NSC3 is expected to enhance NSC training activities, which typically means organizing, standardizing, or expanding training opportunities connected to the centers. That can include coordinating workshops, webinars, short courses, or other skill-building efforts that help investigators, trainees, and staff effectively use NSC cores and services. The coordinating center is also expected to facilitate the sharing of resources, which often implies developing practical systems for resource discovery and access (for example, shared listings or catalogs of available services, protocols, technologies, data-related tools, or other materials). Just as important, the NSC3 must serve as a structured interface between NIA and the NSCs, working with both to develop strategies and plans for continued network development, future directions, and improvements over time.
Applicants are expected to understand the activities and role of the Nathan Shock Centers, but they do not need to be housed within or formally part of an active NSC to apply. Eligibility is broad and includes many types of U.S.-based organizations: state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other organizations that meet NIH eligibility rules. The FOA also explicitly notes categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, foreign participation is restricted: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed.
From an administrative standpoint, this opportunity is categorized as discretionary funding and sits in the health area under CFDA 93.866. The FOA lists an award ceiling of $350,000. The original closing date shown is October 22, 2019, and the creation date is June 28, 2019, which indicates this particular posting reflects a past application cycle; anyone interested in pursuing something similar would typically look for a current reissue, renewal, or successor FOA from NIA/NIH.
In practical terms, a competitive NSC3 application would be expected to lay out a clear coordination plan, communication and dissemination strategies to boost visibility, mechanisms to foster cross-center collaboration, a concrete approach to training support, and workable systems for resource sharing. Because it is a cooperative agreement, the proposal would also need to show how the applicant will coordinate effectively with NIA and with the NSCs, including governance, feedback loops, and planning processes that support continuous improvement of the network.Apply for RFA AG 20 021
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2019-06-28.
- Applicants must submit their applications by 2019-10-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER)
Previous opportunity: Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 20 021
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 021) also looked into and applied for these:
| Funding Opportunity |
|---|
| Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA NS 20 004 Funding Number: RFA NS 20 004 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 19 312 Funding Number: PAR 19 312 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 19 315 Funding Number: PAR 19 315 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 19 011 Funding Number: RFA RM 19 011 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) Apply for PAR 19 311 Funding Number: PAR 19 311 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 19 313 Funding Number: PAR 19 313 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 20 001 Funding Number: RFA AA 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) Apply for RFA AA 20 002 Funding Number: RFA AA 20 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 19 314 Funding Number: PAR 19 314 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Partnerships Initiative (NPI) – Global Health Apply for 7200AA19APS00013 Funding Number: 7200AA19APS00013 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Connecting Kids to Coverage (CKC) HEALTHY KIDS AI/AN Apply for CMS 2D2 20 001 Funding Number: CMS 2D2 20 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $750,000 |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) Apply for PAS 19 316 Funding Number: PAS 19 316 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) Apply for PAS 19 317 Funding Number: PAS 19 317 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 20 011 Funding Number: RFA AG 20 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 20 010 Funding Number: RFA AG 20 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 030 Funding Number: RFA AG 20 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21) Apply for RFA AT 20 001 Funding Number: RFA AT 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 19 328 Funding Number: PAR 19 328 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 19 329 Funding Number: PAR 19 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 19 330 Funding Number: PAR 19 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 021", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
